Ngā hua rapu - Stephanos Ioannidis
- E whakaatu ana i te 1 - 8 hua o te 8
-
1
Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2 mā Joseph M. Gozgit, Geraldine Bebernitz, Pankaj Patil, Minwei Ye, Julie Parmentier, Jiaquan Wu, Nancy Su, Tao Wang, Stephanos Ioannidis, Audrey M. Davies, Dennis Huszar, Michael Zinda
I whakaputaina 2008Artigo -
2
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors mā Michael Hedvat, Dennis Huszar, Andreas Herrmann, Joseph M. Gozgit, Anne Schroeder, Adam Sheehy, Ralf Buettner, David A. Proia, Claudia Kowolik, Xin Hong, Brian Armstrong, Geraldine Bebernitz, Shaobu Weng, Lin Wang, Minwei Ye, Kristen McEachern, Huawei Chen, Deborah Morosini, Kirsten Bell, Marat Alimzhanov, Stephanos Ioannidis, Patricia McCoon, Zhu Cao, Hua Yu, Richard Jove, Michael Zinda
I whakaputaina 2009Artigo -
3
The deubiquitylase USP9X controls ribosomal stalling mā Anne Clancy, Claire Heride, Adán Pinto-Fernández, Hannah Elcocks, Andreas Kallinos, Katherine J. Kayser-Bricker, Weiping Wang, Victoria Smith, Simon Davis, Shawn P. Fessler, Crystal McKinnon, Marie Katz, Tim Hammonds, Neil P. Jones, Jonathan C. O’Connell, Bruce Follows, Steven Mischke, Justin A. Caravella, Stephanos Ioannidis, Christopher J. Dinsmore, Sunkyu Kim, Axel Behrens, David Komander, Benedikt M. Kessler, Sylvie Urbé, Michael J. Clague
I whakaputaina 2021Artigo -
4
Pyrimidinone Nicotinamide Mimetics as Selective Tankyrase and Wnt Pathway Inhibitors Suitable for in Vivo Pharmacology mā Jeffrey W. Johannes, Lynsie Almeida, Bernard Barlaam, P. Ann Boriack‐Sjodin, Robert Casella, Rosemary A. Croft, Allan Dishington, Lakshmaiah Gingipalli, Chungang Gu, Janet Hawkins, J. L. Holmes, Tina Howard, Jian Huang, Stephanos Ioannidis, Steven L. Kazmirski, Michelle L. Lamb, Thomas M. McGuire, Jane E. Moore, D. Ogg, Anil S. Patel, Kurt G. Pike, Timothy Pontz, Graeme R. Robb, Nancy Su, Haiyun Wang, Xiaoyun Wu, Haijun Zhang, Yue Zhang, Xiaolan Zheng, Tao Wang
I whakaputaina 2015Artigo -
5
USP30 sets a trigger threshold for PINK1–PARKIN amplification of mitochondrial ubiquitylation mā Emma V. Rusilowicz-Jones, Jane Jardine, Andreas Kallinos, Adán Pinto-Fernández, Franziska Guenther, Mariacarmela Giurrandino, Francesco G. Barone, Katy R. McCarron, Christopher J. Burke, Alejandro Murad, Aitor Martinez, Elena Marcassa, Malte Gersch, Alexandre J. Buckmelter, Katherine J. Kayser-Bricker, Frédéric Lamoliatte, Akshada Gajbhiye, Simon Davis, Hannah C. Scott, Emma J. Murphy, Katherine S. England, Heather Mortiboys, David Komander, Matthias Trost, Benedikt M. Kessler, Stephanos Ioannidis, Michael K. Ahlijanian, Sylvie Urbé, Michael J. Clague
I whakaputaina 2020Artigo -
6
USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma mā E. Josue Ruiz, Adán Pinto-Fernández, A.P. Turnbull, Linxiang Lan, Thomas M. Charlton, Hannah C. Scott, Andreas Damianou, George Vere, Eva M. Riising, Clive Da Costa, Wojciech Krajewski, David Guerin, Jeffrey D. Kearns, Stephanos Ioannidis, Marie Katz, Crystal McKinnon, Jonathan C. O’Connell, Natalia Moncaut, Ian Rosewell, Emma Nye, Neil P. Jones, Claire Heride, Malte Gersch, Min Wu, Christopher J. Dinsmore, Tim Hammonds, Sunkyu Kim, David Komander, Sylvie Urbé, Michael J. Clague, Benedikt M. Kessler, Axel Behrens
I whakaputaina 2021Artigo -
7
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia mā Srividya B. Balachander, Steven W. Criscione, Kate F. Byth, Justin Cidado, Ammar Adam, Paula Lewis, Terry Macintyre, Shenghua Wen, Deborah Lawson, Kathleen A. Burke, Tristan Lubinski, Jeffrey W. Tyner, Stephen E. Kurtz, Shannon K. McWeeney, Jeffrey Varnes, R. Bruce Diebold, Thomas W. Gero, Stephanos Ioannidis, Edward J. Hennessy, William McCoull, Jamal Saeh, Areya Tabatabai, Omid Tavana, Nancy Su, Alwin G. Schuller, Mathew J. Garnett, Patricia Jaaks, Elizabeth A. Coker, Gareth P. Gregory, Andrea Newbold, Ricky W. Johnstone, Eric T. Gangl, Martin Wild, Michael Zinda, J. Paul Secrist, Barry R. Davies, Stephen E. Fawell, Francis D. Gibbons
I whakaputaina 2020Artigo -
8
Molecular basis of USP7 inhibition by selective small-molecule inhibitors mā A.P. Turnbull, Stephanos Ioannidis, Wojciech Krajewski, Adán Pinto-Fernández, Claire Heride, Agnés C. L. Martin, Louise M. Tonkin, Elizabeth C. Townsend, Shane M. Buker, David R. Lancia, Justin A. Caravella, Angela V. Toms, Thomas M. Charlton, Johanna Lahdenranta, Erik Wilker, Bruce Follows, Nicola J. Evans, Lucy F. Stead, Cristina Alli, Vladislav Zarayskiy, Adam C. Talbot, Alexandre J. Buckmelter, Minghua Wang, Crystal McKinnon, Fabienne Saab, Joanna F. McGouran, Hannah Century, Malte Gersch, Marc S. Pittman, C. Gary Marshall, Tony Raynham, Mary Ellen Simcox, Lorna Stewart, Sheila B. McLoughlin, Jaime A. Escobedo, Kenneth W. Bair, Christopher J. Dinsmore, Tim Hammonds, Sunkyu Kim, Sylvie Urbé, Michael J. Clague, Benedikt M. Kessler, David Komander
I whakaputaina 2017Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Biochemistry
Chemistry
Cancer research
Cell biology
Genetics
Medicine
Apoptosis
Enzyme
Gene
Signal transduction
Ubiquitin
Bcl-xL
Cancer
Cell growth
Computational biology
Growth inhibition
In vivo
Internal medicine
Pathology
Pharmacology
Programmed cell death
Protease
Ubiquitin ligase
Autophagy
Bcl-2 family
Biotechnology
Carcinogenesis
Carcinoma
Cell